This is a study for participants with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have already received treatment. The main purpose is to compare pirtobrutinib to other drugs that have already been approved by the United States Food and Drug Administration (US FDA) for CLL/SLL.
Have chronic lymphocytic leukemia or small lymphocytic lymphoma that requires treatment
Have received prior treatment, including with a type of medicine called a BTK inhibitor
Be well enough to perform their own personal care
Have adequate organ function and blood counts, as measured by blood tests
Have cancer that has become very aggressive or has spread to the brain or spinal cord
Have serious heart disease
Need a blood thinner called warfarin
Have any problems absorbing food or medicine taken by mouth
Take certain medicines that affect how fast the study drug is broken down in the body
Have active infection
By volunteering to take part in Leukemia and Lymphoma clinical trials, you may be able to play an important role in the research and development of potential new treatments and medicines. We understand that when you or a loved one take part in a clinical trial, it is a big decision. It is important for you to understand why the research is being carried out and what taking part will mean for you. Learn more about Lilly
Leukemia + Lymphoma Research
Lilly has been involved in cancer research for more than fifty years, working to improve the lives of people living with cancer. Learn more about cancer research at Lilly and how you can make an impact.
Learn More
A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.